Denise Pereira

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study

Volkan Granit, Michael Benatar, Metin Kurtoğlu et al. · The Lancet Neurology · 2023 · 216 citations · Full text

Allergy, Autoimmune Disease, Non-randomised Phase 1B/2a +6

A Long-term Retrospective Study of Young Women With Essential Thrombocythemia

Ayalew Tefferi, Rafaël Fonseca, Denise Pereira et al. · Mayo Clinic Proceedings · 2001 · 133 citations

Thrombopoiesis, Thrombosis, Venous Thrombosis +8

Incidence and risk factors associated with a syndrome of persistent cytopenias after CAR-T cell therapy (PCTT)

George Nahas, Krishna V. Komanduri, Denise Pereira et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2019 · 101 citations

Immunodeficiencies, T-regulatory Cell, Immunology +24

Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome

Peter Mollee, Ashutosh Wechalekar, Denise Pereira et al. · Bone Marrow Transplantation · 2003 · 70 citations

Regenerative Medicine, Alzheimer's Disease, Transplantation +8

Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation Recipients

José F. Camargo, Erik L. Kimble, Rossana Rosa et al. · Biology of Blood and Marrow Transplantation · 2017 · 70 citations · Full text